Cleared Traditional

K833842 - RIA COAT DIGOXIN

K833842 is the FDA 510(k) clearance for RIA COAT DIGOXIN by Immuno Assay Corp.. It is a Class 2 Toxicology device (product code DPO) cleared through the Traditional 510(k) pathway after a 75-day FDA review.

K833842 · Immuno Assay Corp. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1984
Decision
75d
Days
Class 2
Risk

K833842 is an FDA 510(k) clearance for the RIA COAT DIGOXIN. Classified as Radioimmunoassay, Digoxin (125-i), Rabbit Antibody, Coated Tube Sep. (product code DPO), Class II - Special Controls.

Submitted by Immuno Assay Corp. (Mchenry, US). The FDA issued a Cleared decision on January 17, 1984 after a review of 75 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3320 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Immuno Assay Corp. devices

Submission Details

510(k) Number K833842 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 03, 1983
Decision Date January 17, 1984
Days to Decision 75 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
12d faster than avg
Panel avg: 87d · This submission: 75d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DPO Radioimmunoassay, Digoxin (125-i), Rabbit Antibody, Coated Tube Sep.
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - DPO Radioimmunoassay, Digoxin (125-i), Rabbit Antibody, Coated Tube Sep.

All 9
Devices cleared under the same product code (DPO) and FDA review panel - the closest regulatory comparables to K833842.
SOPHEIA DIGOXIN EIA KIT
K832163 · Diagnostic Products Corp. · Aug 1983
COAT-A-COUNT DIGOXIN RIA
K811932 · Diagnostic Products Corp. · Jul 1981
KALLESTAD QUANTICOAT 125 DIGOXIN
K811776 · Kallestad Laboratories, Inc. · Jul 1981
RIA PHASE DIGOXIN
K800205 · Boehringer Mannheim Corp. · Mar 1980
AUTOPAK 12 DIGOXIN TEST DELIVERY SYSTEM
K791325 · Micromedic Systems · Aug 1979
VENTRE/SEP DIGOXIN RADIOIMMUNOASSAY KIT
K791355 · Ventrex Laboratories, Inc. · Aug 1979